Ignacio Pérez de Castro

Years Active: 2020-2022
Publications (10 Years): 2

Instituto de Salud Carlos III

Universidad Autónoma de Madrid (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Instituto de Salud Carlos III Mar 01 2016

Spain

Group Leader :: Instituto de Investigación de Enfermedades Raras

Centro Nacional de Investigaciones Oncológicas Jan 01 2004 - Feb 29 2016

Spain

Staff Scientist :: Molecular Oncology

New York University School of Medicine

United States

Assistant Research Scientist :: Pathology

Education History

Universidad Autónoma de Madrid

Spain

PHD :: Biology

Publications

Alberto Martín, Carolina Epifano, Borja Vilaplana-Marti, Iván Hernández, Rocío I R Macías, Ángel Martínez-Ramírez, Ana Cerezo, Pablo Cabezas-Sainz, Maria Garranzo-Asensio, Sandra Amarilla-Quintana, Déborah Gómez-Domínguez, Eduardo Caleiras, Jordi Camps, Gonzalo Gómez-López, Marta Gómez de Cedrón, Ana Ramírez de Molina, Rodrigo Barderas, Laura Sánchez, Susana Velasco-Miguel, Ignacio Pérez de Castro
Mitochondrial RNA methyltransferase TRMT61B is a new, potential biomarker and therapeutic target for highly aneuploid cancers. Cell death and differentiation (2022)
Berta Segura-Collar, Ricardo Gargini, Elena Tovar-Ambel, Esther Hernandez-SanMiguel, Carolina Epifano, Ignacio Pérez de Castro, Aurelio Hernández-Laín, Sergio Casas-Tintó, Vicente A Torres
The EGFR-TMEM167A-p53 Axis Defines the Aggressiveness of Gliomas. Cancers 12 (1) (2020)

Ignacio Pérez de Castro.css-eqlu8i{font-size:small;padding-left:4px;}